Related references
Note: Only part of the references are listed.New Approaches in the Treatment of Hypertension
Suzanne Oparil et al.
CIRCULATION RESEARCH (2015)
MAS C-Terminal Tail Interacting Proteins Identified by Mass Spectrometry- Based Proteomic Approach
Kalyan C. Tirupula et al.
PLOS ONE (2015)
Transactivation of ErbB Family of Receptor Tyrosine Kinases Is Inhibited by Angiotensin-(1-7) via Its Mas Receptor
Saghir Akhtar et al.
PLOS ONE (2015)
Potential of the Angiotensin Receptor Blockers (ARBs) Telmisartan, Irbesartan, and Candesartan for Inhibiting the HMGB1/RAGE Axis in Prevention and Acute Treatment of Stroke
Kiyoshi Kikuchi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Changes in Urinary Albumin Excretion, Inflammatory and Oxidative Stress Markers in ADPKD Patients with Hypertension
Tsukasa Nakamura et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2012)
Emergence and evolution of the renin-angiotensin-aldosterone system
David Fournier et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2012)
A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release
Huan Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Angiotensin-converting enzyme 2 gene targeting studies in mice: mixed messages
Susan B. Gurley et al.
EXPERIMENTAL PHYSIOLOGY (2008)
HMGB1: Endogenous danger signaling
John R. Klune et al.
MOLECULAR MEDICINE (2008)
HMG proteins: dynamic players in gene regulation and differentiation
ME Bianchi et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2005)
High-mobility group box 1 protein (HMGB): Nuclear weapon in the immune arsenal
MT Lotze et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes
E Mervaala et al.
HYPERTENSION (2000)
Share Paper
